0001144204-18-059266.txt : 20181113
0001144204-18-059266.hdr.sgml : 20181113
20181113143153
ACCESSION NUMBER: 0001144204-18-059266
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180930
FILED AS OF DATE: 20181113
DATE AS OF CHANGE: 20181113
EFFECTIVENESS DATE: 20181113
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foresite Capital Management II, LLC
CENTRAL INDEX KEY: 0001594912
IRS NUMBER: 464028844
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16497
FILM NUMBER: 181177265
BUSINESS ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001594912
XXXXXXXX
09-30-2018
09-30-2018
false
Foresite Capital Management II, LLC
600 Montgomery Street
Suite 4500
San Francisco
CA
94111
13F HOLDINGS REPORT
028-16497
N
James B. Tananbaum
Managing Member
415-877-4887
/s/ James B. Tananbaum
San Francisco
CA
11-13-2018
0
10
270204
INFORMATION TABLE
2
infotable.xml
Acceleron Pharma Inc.
COM
00434H108
12606
220268
SH
SOLE
220268
0
0
Adaptimmune Therapeutics PLC
SPONDS ADR
00653A107
6780
500000
SH
SOLE
500000
0
0
Aerie Pharmaceuticals, Inc.
COM
00771V108
90155
1464749
SH
SOLE
1464749
0
0
Aimmune Therapeutics, Inc.
COM
00900T107
90046
3300797
SH
SOLE
3300797
0
0
Alder BioPharmaceuticals, Inc.
COM
014339105
26411
1586220
SH
SOLE
1586220
0
0
BioDelivery Sciences International, Inc.
COM
09060J106
2658
949233
SH
SOLE
949233
0
0
Denali Therapeutics Inc.
COM
24823R105
5435
250000
SH
SOLE
250000
0
0
Epizyme, Inc.
COM
29428V104
15183
1432364
SH
SOLE
1432364
0
0
Insmed Incorporated
COM
457669307
19566
967636
SH
SOLE
967636
0
0
Sangamo Therapeutics, Inc.
COM
800677106
1364
80500
SH
SOLE
80500
0
0